Loading
Loading…
Loading…
| # | Schedule | Awarded To | Bids | Value |
|---|---|---|---|---|
| 1 | Schedule 1 | PHARMA (INDIA) | 3 | ₹52,920 |
| 2 | Schedule 2 | FAIRDEAL HEALTH CARE PRIVATE LIMITED | 5 | ₹10,080 |
| 3 | Schedule 3 | PHARMA (INDIA) | 5 | ₹6,270 |
| 4 | Schedule 4 | PHARMA (INDIA) | 5 | ₹16,800 |
| 5 | Schedule 5 | PHARMA (INDIA) | 6 | ₹10,950 |
Tender Value
Refer Docs
EMD Value
Exempted
Closing Date
21 May 2026, 1:00 pmClosed
LOPINAVIR 200 MG PLUS RITONAVIR 50 MG TAB
MEMANTINE 5 MG TAB
METHOTREXATE 10 MG TAB
METOPROLOL SR 25 MG TAB
MONTELUKAST 10 MG TAB
NEBIVOLOL 5 MG TAB
NEVIRAPINE 200 MG TAB
9287894
GEM/2026/B/7502474
Two Packet Bid
LOPINAVIR 200 MG PLUS RITONAVIR 50 MG TAB,MEMANTINE 5 MG TAB,METHOTREXATE 10 MG TAB,METOPROLOL SR 2
Mumbai, Maharashtra
Item wise evaluation
BOQ
7 documents required · 7 mandatory
2 yrs
₹1 L
₹1 L
20%
Exempted
Yes
21 May 2026
11 May 2026
21 May 2026
| Item No | Item Title | Qty | Unit | Consignee | Delivery (days) |
|---|---|---|---|---|---|
| 1 | LOPINAVIR 200 MG PLUS RITONAVIR 50 MG TAB | 3,600 | NO | Mumbai | 30 |
| 2 | MEMANTINE 5 MG TAB | 21,000 | NO | Mumbai | 30 |
| 3 | METHOTREXATE 10 MG TAB | 3,300 | NO | Mumbai | 30 |
| 4 | METOPROLOL SR 25 MG TAB | 42,000 | NO | Mumbai | 30 |
| 5 | MONTELUKAST 10 MG TAB | 15,000 | NO | Mumbai | 30 |
| 6 | NEBIVOLOL 5 MG TAB | 33,000 | NO | Mumbai | 30 |
| 7 | NEVIRAPINE 200 MG TAB | 3,600 | NO | Mumbai | 30 |
Tap a document below to read it instantly. You can also download everything as a ZIP if you prefer.
bid_9287894.pdf
GEM_BID • 0.14 MB
bb_qr_2026-05-05-10-47-07_8203528e40d1bd75b0e455770ea87917.pdf
BOQ • 0.36 MB
boq_item_sample_file-3_2026-05-05-10-47-07_b8c953fca4b2472cbce93f15b9ced4a1.csv
BOQ • 0.00 MB
gtc.pdf
GEM_OTHER • 0.71 MB
Download all tender documents and submit your bid
Disclaimer: TenderKart has made every reasonable effort to ensure that the information on this page is accurate and authentic, however it cannot be held liable for any third-party claims or losses or any damages. TenderKart makes no warranty, expressed or implied, as to the results obtained from the use of this information. If you notice any error or omission, please let us know at .